Form 4: Senseonics CEO Buys 17,225 Shares in Planned Transaction

Senseonics Holdings, Inc. President and CEO Timothy T. Goodnow acquired 17,225 shares of common stock through a pre-planned transaction.

Summary

• Timothy T. Goodnow, President and CEO, and a Director of Senseonics Holdings, Inc. (SENS), acquired 17,225 shares of common stock.
• The transaction occurred on March 13, 2026, at a weighted average price of $5.79 per share, with prices ranging from $5.75 to $5.8099.
• The purchase was executed under a Rule 10b5-1 pre-arranged trading plan.
• Following this transaction, Goodnow directly beneficially owns 651,243 shares of Senseonics common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a CEO's purchase of company stock, even if pre-planned, typically reflects confidence in the company's future prospects and valuation.

Positives

• An insider, the President and CEO, purchased shares, which can signal confidence in the company's future prospects.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned investment strategy and reducing concerns about opportunistic timing.

Future Outlook

This filing does not contain forward-looking statements or guidance beyond the reported transaction.

Industry Context

StockSavvy.ai notes that insider purchases, especially by a CEO, are often viewed positively by the market as they can indicate management's belief in the company's undervaluation or strong future performance, particularly within the medical device or healthcare technology sector where Senseonics operates.

Comparison to Industry Standards

• Insider buying activity is a common occurrence across industries. While the specific amount of shares purchased by Senseonics' CEO is notable for an individual, it's difficult to compare directly to industry benchmarks without knowing the CEO's total compensation or the company's market capitalization.
• Similar insider purchases have been observed in other medical technology companies like Dexcom (DXCM) or Abbott Laboratories (ABT) where executives occasionally increase their holdings, signaling confidence in their respective continuous glucose monitoring or broader healthcare portfolios.

Corporate Governance

Related Party Transactions

• Timothy T. Goodnow, President and CEO, purchased 17,225 shares of Senseonics Holdings, Inc. common stock.

Stakeholder Impact

• Shareholders may view the CEO's purchase as a positive signal of confidence, potentially influencing investor sentiment.
• Employees could interpret the CEO's investment as a sign of stability and belief in the company's long-term vision.

Key Dates

Recommendation

The CEO's purchase of company stock, even under a 10b5-1 plan, is a positive indicator of management confidence. However, without additional financial performance data or strategic updates, this single transaction primarily reinforces a 'hold' position for current investors and suggests further due diligence for prospective investors rather than an immediate 'buy' or 'sell' signal.

Keywords

Senseonics Holdings, SENS, Insider Trading, Stock Purchase, CEO, Timothy T. Goodnow, Form 4, Beneficial Ownership, Rule 10b5-1